Clinical trials
Terminated Phase 3 Schizophrenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 4 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 |
| AstraZeneca | 4 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 4 |
| Denovo Biopharma LLC | 3 |
| H. Lundbeck A/S | 3 |
| Shire | 3 |
| AbbVie | 2 |
| Hannover Medical School | 2 |
| M. Schaefer, MD | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 43 |
| Psychotic Disorders | 7 |
| Bipolar Disorder | 2 |
| Cognitive Dysfunction | 2 |
| Metabolic Syndrome | 2 |
| Anxiety Disorders | 1 |
| Body Weight Changes | 1 |
| Dementia | 1 |
| Mania | 1 |
| Psychophysiologic Disorders | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.